BethZelenakClarkMD

PubMed

• Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retros...
  Lakshmi Harinath, Tatiana M Villatoro, Beth Z Clark, Jeffrey L Fine, Jing Yu, Gloria J Carter, Emilia Diego, Priscilla F McAuliffe, Phuong Mai, Amy Lu, Margarita Zuley...> ;Modern Pathology. 2024 Feb 28
• Implementation of Digital Image Analysis in Assessment of Ki67 Index in Breast Cancer.
  Rachel K Vanderschelden, Daniel Gonzalez, Lindsey Seigh, Gloria J Carter, Beth Z Clark, Esther Elishaev, Jeffrey Louis Fine, Lakshmi Harinath, Mirka W Jones, Tatiana M...> ;Applied Immunohistochemistry & Molecular Morphology. 2024 Jan 1
• Erratum to Metaplastic Breast Carcinoma: A Clinical-Pathologic Study of 97 Cases With Subset Analysis of Response to Neoadjuvant Chemotherapy [Modern Pathology 32(6) (...
  Min Han, Arsalan Salamat, Li Zhu, Huina Zhang, Beth Z Clark, David J Dabbs, Gloria J Carter, Adam M Brufsky, Rachel C Jankowitz, Shannon L Puhalla, Ronald R Johnson, A...> ;Modern Pathology. 2023 Aug 1
• 1 citations
  Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
  Jing Yu, Edaise M da Silva, Hae-Sun La, Beth Z Clark, Jeffrey L Fine, Gloria J Carter, Tatiana M Villatoro, T Rinda Soong, Adrian V Lee, Steffi Oesterreich, Thais Basi...> ;NPJ Breast Cancer. 2023 Jul 13
• 1 citations
  Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumors.
  Rayan Rammal, Kanika Goel, Esther Elishaev, T Rinda Soong, Mirka W Jones, Chengquan Zhao, Beth Z Clark, Gloria J Carter, Jing Yu, Jeffrey L Fine, Tatiana M Villatoro, ...> ;American Journal of Clinical Pathology. 2023 Oct 3
• 1 citations
  Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive see...
  Beth Z Clark, Ronald R Johnson, Wendie A Berg, Priscilla McAuliffe, Rohit Bhargava> ;Breast Cancer Research and Treatment. 2023 Aug 1
• 1 citations
  Changes over time in papanicolaou cytology test and HPV test in a large women's academic center laboratory.
  Terri E Jones, Jonee Matsko, Esther Elishaev, Beth Z Clark, Gloria Carter, Lakshmi Harinath, Chengquan Zhao> ;Journal of the American Society of Cytopathology. 2023 Apr 7
• Ovarian serous borderline tumor with mural nodules of anaplastic carcinoma and omental involvement: A case report.
  Paula I Hernandez Acevedo, Gloria J Carter, Madeleine Courtney-Brooks, Beth Z Clark> ;Rare Tumors. 2023 Jan 1
• 4 citations
  The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
  Rayan Rammal, Kanika Goel, Esther Elishaev, T Rinda Soong, Mirka W Jones, Chengquan Zhao, Beth Z Clark, Gloria J Carter, Jing Yu, Jeffrey L Fine, Tatiana M Villatoro, ...> ;American Journal of Clinical Pathology. 2022 Nov 3
• Prognostic Significance of Three-Tiered World Health Organization Classification of Phyllodes Tumor and Correlation to Singapore General Hospital Nomogram.
  Davsheen Bedi, Beth Z Clark, Gloria J Carter, Jing Yu, Jeffrey L Fine, Tatiana M Villatoro, Rohit Bhargava> ;American Journal of Clinical Pathology. 2022 Sep 2
• 6 citations
  Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers.
  Pooja Srivastava, Tiannan Wang, Beth Z Clark, Jing Yu, Jeffrey L Fine, Tatiana M Villatoro, Gloria J Carter, Adam M Brufsky, Vikram C Gorantla, Shannon L Huggins-Puhal...> ;NPJ Breast Cancer. 2022 Apr 20
• 13 citations
  Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study
  Rohit Bhargava, Nicole Nicosia Esposito, Siobhan M. OʹConnor, Zaibo Li, Bradley M. Turner, Ioana Moisini, Aditi Ranade, Ronald P. Harris, Dylan V. Miller, Xiaoxian Li,...> ;Modern Pathology. 2021 Jan 1
• 8 citations
  Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis
  Swikrity Upadhyay Baskota, David J. Dabbs, Beth Z. Clark, Rohit Bhargava> ;Modern Pathology. 2021 Jan 1
• 25 citations
  The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer.
  Rohit Bhargava, Beth Z. Clark, Gloria Carter, Adam Brufsky, David J. Dabbs> ;Modern Pathology. 2020 Mar 17
• 10 citations
  Isolated Flat Epithelial Atypia on Core Biopsy Specimens Is Associated With a Low Risk of Upgrade at Excision
  Sarah B Hugar, Rohit Bhargava, David J. Dabbs, Katie M Davis, Margarita L. Zuley, Beth Z. Clark> ;American Journal of Clinical Pathology. 2019 Apr 2
• 21 citations
  Breast cancer global tumor biomarkers: a quality assurance study of intratumoral heterogeneity.
  Beth Z. Clark, Agnieszka Onisko, Binara Assylbekova, Xin Li, Rohit Bhargava, David J. Dabbs> ;Modern Pathology. 2019 Mar 1
• 45 citations
  Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy.
  Min Han, Arsalan Salamat, Li Zhu, Huina Zhang, Beth Z. Clark, David J. Dabbs, Gloria Carter, Adam Brufsky, Rachel C. Jankowitz, Shannon Puhalla, Ronald Johnson, Atilla...> ;Modern Pathology. 2019 Feb 5
• 19 citations
  Breast Cancers With Magee Equation Score of Less Than 18, or 18-25 and Mitosis Score of 1, Do Not Require Oncotype DX Testing: A Value Study.
  Rohit Bhargava, Beth Z. Clark, David J. Dabbs> ;American Journal of Clinical Pathology. 2019 Feb 4
• 5 citations
  High Fidelity of Breast Biomarker Metrics: A 10-Year Experience in a Single, Large Academic Institution.
  Huina Zhang, Min Han, Kavita R. Varma, Beth Z. Clark, Rohit Bhargava, David J. Dabbs> ;Applied Immunohistochemistry & Molecular Morphology. 2018 Nov 1
• 3 citations
  Pathologist's health-care value in the triage of Oncotype DX® testing: a value-based pathology study of tumour biology with outcomes.
  David J. Dabbs, Beth Z. Clark, Kate Serdy, Agnieszka Onisko, Adam Brufsky, Sherie Smalley, Stephen Perkins, Rohit Bhargava> ;Histopathology. 2018 Oct 1
• 42 citations
  Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?
  Alessandra Landmann, Daniel J. Farrugia, Li Zhu, Emilia J Diego, Ronald Johnson, Atilla Soran, David J. Dabbs, Beth Z. Clark, Shannon Puhalla, Rachel C. Jankowitz, Ada...> ;American Journal of Clinical Pathology. 2018 May 31
• Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.
  Beth Z. Clark, Daniel J. Farrugia, Alessandra Landmann, Emilia J Diego, David J. Dabbs, Shannon Puhalla, Rachel C. Jankowitz, Adam Brufsky, Gretchen M. Ahrendt, Prisci...> ;American Journal of Clinical Pathology. 2018 Mar 7
• 6 citations
  Effects of Hydrochloric Acid and Formic Acid Decalcification on Breast Tumor Biomarkers and HER2 Fluorescence In Situ Hybridization.
  Beth Z. Clark, Jennifer M. Yoest, Agnieszka Onisko, David J. Dabbs> ;Applied Immunohistochemistry & Molecular Morphology. 2017 Sep 1
• 28 citations
  Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors
  Daniel J. Farrugia, Alessandra Landmann, Li Zhu, Emilia J Diego, Ronald Johnson, Marguerite Bonaventura, Atilla Soran, David J. Dabbs, Beth Z. Clark, Shannon Puhalla, ...> ;Modern Pathology. 2017 May 26
• 17 citations
  An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
  Theresa A. Koleck, Catherine M. Bender, Beth Z. Clark, Christopher M. Ryan, Puja Ghotkar, Adam Brufsky, Priscilla F. McAuliffe, Priya Rastogi, Susan M. Sereika, Yvette...> ;Breast Cancer. 2017 Mar 3
• Join now to see all